In recent trading session today, 36.55 million shares of the Virios Therapeutics Inc (NASDAQ:VIRI) have been traded, and its beta is 1.62. Most recently the company’s share price was $0.15, and it changed around $0.01 or 10.01% from the last close, which brings the market valuation of the company to $4.21M. VIRI at last check was trading at a discount to its 52-week high of $1.04, offering almost -593.33% off that amount. The share price’s 52-week low was $0.13, which indicates that the recent value has risen by an impressive 13.33% since then. We note from Virios Therapeutics Inc’s average daily trading volume that its 10-day average is 0.83 million shares, with the 3-month average coming to 1.01 million.
Virios Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended VIRI as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Virios Therapeutics Inc is expected to report earnings per share of -0.05 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Virios Therapeutics Inc (NASDAQ:VIRI) trade information
Instantly VIRI has been showing a green trend so far today with a performance of 10.01% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2068 on recent trading dayincreased the stock’s daily price by 27.47%. The company’s shares are currently down -73.62% year-to-date, but still down -2.63% over the last five days. On the other hand, Virios Therapeutics Inc (NASDAQ:VIRI) is -16.19% down in the 30-day period. We can see from the shorts that 0.47 million shares have been sold at a short interest cover period of 0.64 day(s).
Virios Therapeutics Inc (VIRI) estimates and forecasts
Virios Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -67.33 percent over the past six months and at a 21.43% annual growth rate that is well above the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 16.70% in revenue this quarter, and will report an increase of 16.70% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.02%.
VIRI Dividends
Virios Therapeutics Inc’s next quarterly earnings report is expected to be released on 2024-Nov-11.
Virios Therapeutics Inc (NASDAQ:VIRI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 6.74% of Virios Therapeutics Inc shares, and 3.60% of them are in the hands of institutional investors. The stock currently has a share float of 3.86%. Virios Therapeutics Inc stock is held by 26.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 1.0847% of the shares, which is about 0.21 million shares worth $44910.0.
GEODE CAPITAL MANAGEMENT, LLC, with 0.906% or 0.17 million shares worth $37516.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
